Beta-Cell Function Is the Dominant Baseline Determinant of Type 2 Diabetes Remission in Response to Short-Term Insulin-Based Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Baseline determinants of remission of type 2 diabetes in response to short-term insulin-based therapy: The pivotal role of beta-cell function
Diabetes Obes Metab 2023 Jun 28;[EPub Ahead of Print], R Retnakaran, J Pu, A Emery, CK Kramer, B ZinmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.